Trademark: 90708918
Status Date
Tuesday, December 13, 2022
Registration Number
6926111
Registration Date
Tuesday, December 13, 2022
Filing Date
Thursday, May 13, 2021
Published for Opposition
Tuesday, January 25, 2022
5 Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
Jun 1, 2023
Teas Change Of Correspondence Received
Jun 1, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 1, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 1, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 1, 2023
Teas Change Of Owner Address Received
Dec 13, 2022
Notice Of Registration Confirmation Emailed
Dec 13, 2022
Registered-Principal Register
Nov 5, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 4, 2022
Allowed Principal Register - Sou Accepted
Oct 6, 2022
Statement Of Use Processing Complete
Sep 22, 2022
Use Amendment Filed
Oct 5, 2022
Case Assigned To Intent To Use Paralegal
Sep 22, 2022
Teas Statement Of Use Received
Mar 22, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 25, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 25, 2022
Published For Opposition
Jan 5, 2022
Notification Of Notice Of Publication E-Mailed
Dec 20, 2021
Approved For Pub - Principal Register
Dec 13, 2021
Assigned To Examiner
Aug 12, 2021
New Application Office Supplied Data Entered
May 17, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
